0 Biggest Stock Market Gainers

Nvidia is a leading designer of graphics processing units that enhance the experience on computing platforms. The firm's chips are used in a variety of end markets, including high-end PCs for gaming, data centers, and automotive infotainment systems. In recent years, the firm has broadened its focus from traditional PC graphics applications such as gaming to more complex and favorable opportunities, including artificial intelligence and autonomous driving, which leverage the high-performance capabilities of the firm's graphics processing units.

Dexcom designs and commercializes continuous glucose monitoring (CGM) systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company sells three different pieces of equipment, a sensor, a transmitter, and a receiver.

Expedia is the world's largest online travel agency by bookings, offering services for lodging (69% of total 2018 sales), air tickets (8%), rental cars, cruises, in-destination, and other (14%), and advertising revenue (9%). Expedia operates a number of branded travel booking sites, including Expedia.com, Hotels.com, Travelocity, Orbitz, Wotif, AirAsia, Engencia, and Vrbo. It has also expanded into travel media with the acquisition of Trivago. Transaction fees for online bookings account for the bulk of sales and profits.

GoDaddy Inc provides cloud-based products and personalised customer support to small businesses, web design professionals, and individuals. The company maintains an inventory of domain name extensions and operates a marketplace for trading previously owned domains. GoDaddy offers customers website building, hosting, and security tools to construct and protect their online presence. The company's platform provides tools and applications such as domain-specific email, online storage, invoicing, bookkeeping, and payment solutions, which help clients manage their businesses.

Bio-Rad Laboratories manufactures and supplies systems used to separate and analyze chemical and biological materials to life sciences and healthcare companies. The firm has two business segments: life science and clinical diagnostics. The life sciences segment manufactures reagents and laboratory instruments used by researchers, food producers, and pharmaceutical manufacturers. The clinical diagnostics segment generates over half of the firm's revenue and creates tests systems, informatics systems, test kits, and specialized quality controls for diagnostic labs. It also sells in vitro diagnostic tests to clinical laboratories. Most of the firm's revenue is generated from the United States and Europe.